A cancer diagnosis carries incredible burdens. That’s why we pursue new therapies, work to help expand access to medicines, provide support, and learn from patients every day. At Sanofi, we are dedicated to delivering cancer care that fits in the lives of people living with this disease. We’re pushing the boundaries of scientific innovation to make meaningful breakthroughs and expand access to our treatments. Together, with leaders and partners in the healthcare community, we’re working to address critical gaps in care and translate scientific discoveries into potential new treatment options and standards of care. With new technologies unlocking a world of possibilities, our robust oncology pipeline demonstrates the progress we’re making to address gaps in oncology treatment, with the hope of transforming what’s possible for people living with cancer.

Schlomit, multiple myeloma, Israel

Did you know?

1 in 3

people in the United States will be diagnosed with cancer during their lifetime1.

1.9 million

new cancer cases were expected to be diagnosed in the United States in 20232.

18 million

Americans live with a history of invasive cancer3.


Cancer is the second most common cause of death in the United States4.

Danielle, multiple myeloma, US
Danielle, multiple myeloma, US

Our commitment to oncology

We’re charging ahead, building on our rich legacy in oncology. With a growing pipeline and renewed commitment to advancing potentially transformative therapies, we’re determined to help improve outcomes and the lives of people living with many different types of cancer.

Don, lung cancer, US
Don, lung cancer, US

Our oncology focus

We’re building a differentiated oncology pipeline, focusing our research on areas of high unmet need. Because our goal is to go beyond the expected and potentially transform the treatment of cancer.